RxDoctor Payments Data

John Mitchell, DO

Psychiatry · Port Huron, MINPI 1043308455

Payments from drug & device makers

$596in general payments, 2019–2025

Across 26 payments — averaging $22.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$159
  • Neurocrine Biosciences, Inc.$103
  • E.r. Squibb & Sons, L.L.C.$64
  • Axsome Therapeutics, Inc.$51
  • Indivior Inc.$47
  • Tris Pharma Inc$41
  • plus $131 from 5 others

What the payments were for

  • Food & beverage$48581%
  • Education$11119%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$596 in reported general payments places this provider in the 65th percentile of 1,166 psychiatry providers in Michigan.

See all psychiatry providers in Michigan

Medicare billing

Part B allowed, 2024
$30,216
Medicare patients
110
Services billed
567

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate181$564,259
Abilify MaintenaAripiprazole99$279,837
IngrezzaValbenazine Tosylate24$187,706
Invega TrinzaPaliperidone Palmitate18$150,115
Austedo XrDeutetrabenazine14$131,619
AristadaAripiprazole Lauroxil24$87,113
AtivanLorazepam11$68,271
VraylarCariprazine Hcl32$45,084
Risperdal ConstaRisperidone Microspheres12$44,481
RexultiBrexpiprazole23$33,992
AuvelityDextromethorphan Hbr/Bupropion24$21,455
VyvanseLisdexamfetamine Dimesylate55$20,630
TrintellixVortioxetine Hydrobromide47$20,249
Paliperidone ErPaliperidone169$14,098
Clozapine350$13,962

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$39$313,829122 claims
Neurocrine Biosciences, Inc.Ingrezza$103$187,70624 claims
Teva Pharmaceuticals USA, Inc.Austedo Xr$159$131,61914 claims
Alkermes, Inc.Aristada$30$87,11324 claims
AbbVieVraylar$13$45,08432 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse, Trintellix$13$40,879102 claims
Axsome Therapeutics, Inc.Auvelity$51$21,45524 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,166 psychiatry providers in Michigan.

Other psychiatry in Port Huron

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →